2306 related articles for article (PubMed ID: 15569772)
21. Activated B cells express CD28/B7-independent costimulatory activity.
Ding L; Shevach EM
J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
Ding L; Shevach EM
J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of enhanced antigen presentation by B cells activated with anti-mu plus interferon-gamma: role of B7-2 in the activation of naive and memory CD4+ T cells.
Morokata T; Kato T; Igarashi O; Nariuchi H
Eur J Immunol; 1995 Jul; 25(7):1992-8. PubMed ID: 7542599
[TBL] [Abstract][Full Text] [Related]
24. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
Tan R; Teh SJ; Ledbetter JA; Linsley PS; Teh HS
J Immunol; 1992 Nov; 149(10):3217-24. PubMed ID: 1385518
[TBL] [Abstract][Full Text] [Related]
25. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M
J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824
[TBL] [Abstract][Full Text] [Related]
26. MRC OX-2 defines a novel T cell costimulatory pathway.
Borriello F; Lederer J; Scott S; Sharpe AH
J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466
[TBL] [Abstract][Full Text] [Related]
27. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
[TBL] [Abstract][Full Text] [Related]
29. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
[TBL] [Abstract][Full Text] [Related]
30. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
Lane P; Haller C; McConnell F
Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
[TBL] [Abstract][Full Text] [Related]
31. High concentrations of antigenic ligand activate and do not tolerize naive CD4 T cells in the absence of CD28/B7 costimulation.
Teh HS; Teh SJ
Cell Immunol; 1997 Jul; 179(1):74-83. PubMed ID: 9259774
[TBL] [Abstract][Full Text] [Related]
32. TCR-independent activation of human CD4+ 45RO- T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype.
Brinkmann V; Kinzel B; Kristofic C
J Immunol; 1996 Jun; 156(11):4100-6. PubMed ID: 8666775
[TBL] [Abstract][Full Text] [Related]
33. CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
Park WR; Park CS; Tomura M; Ahn HJ; Nakahira Y; Iwasaki M; Gao P; Abe R; Hamaoka T; Fujiwara H
Eur J Immunol; 2001 May; 31(5):1456-64. PubMed ID: 11465102
[TBL] [Abstract][Full Text] [Related]
34. Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles.
Parra E; Wingren AG; Hedlund G; Björklund M; Sjögren HO; Kalland T; Sansom D; Dohlsten M
J Immunol; 1994 Sep; 153(6):2479-87. PubMed ID: 7521363
[TBL] [Abstract][Full Text] [Related]
35. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
Li Y; McGowan P; Hellström I; Hellström KE; Chen L
J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
[TBL] [Abstract][Full Text] [Related]
36. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1.
Chen H; Paul WE
J Immunol; 1997 Sep; 159(5):2240-9. PubMed ID: 9278312
[TBL] [Abstract][Full Text] [Related]
37. Alloreactive gamma delta thymocytes utilize distinct costimulatory signals from peripheral T cells.
Penninger JM; Timms E; Shahinian A; Jezo-Bremond A; Nishina H; Ionescu J; Hedrick SM; Mak TW
J Immunol; 1995 Oct; 155(8):3847-55. PubMed ID: 7561091
[TBL] [Abstract][Full Text] [Related]
38. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
Ding L; Shevach EM
Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
[TBL] [Abstract][Full Text] [Related]
39. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
[TBL] [Abstract][Full Text] [Related]
40. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
Blazar BR; Sharpe AH; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Korngold R; Vallera DA
J Immunol; 1996 Oct; 157(8):3250-9. PubMed ID: 8871619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]